These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5660740)

  • 21. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of cardiogenic shock in myocardial infarction with intraaortic counterpulsation].
    Rumiński W; Markiewicz M; Koziara D; Grzywna R; Lakomski B
    Kardiol Pol; 1993 May; 38(5):323-6. PubMed ID: 8366639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.
    Babaev A; Frederick PD; Pasta DJ; Every N; Sichrovsky T; Hochman JS;
    JAMA; 2005 Jul; 294(4):448-54. PubMed ID: 16046651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypovolemic shock in acute myocardial infarct].
    Nikolić V; Sjerobabski V; Gjurović J; Vukosavić D; Planinc D; Petrac D
    Lijec Vjesn; 1984 Oct; 106(10):417-21. PubMed ID: 6503594
    [No Abstract]   [Full Text] [Related]  

  • 25. [Shock in myocardial infarct].
    Lukomskiĭ PE; Gratsianskiĭ NA
    Kardiologiia; 1968 Jan; 8(1):3-12. PubMed ID: 4871455
    [No Abstract]   [Full Text] [Related]  

  • 26. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.
    Hejmdal A; Boesgaard S; Lindholm MG; Goetze JP
    J Card Fail; 2007 Apr; 13(3):184-8. PubMed ID: 17448415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modern trends in physiopathology and therapy of shock caused by myocardial infarct].
    Jacovella G; Milazzotto F; Masini V
    Clin Ter; 1969 Jul; 50(2):143-75. PubMed ID: 4901914
    [No Abstract]   [Full Text] [Related]  

  • 28. Primary angioplasty for acute myocardial infarction complicated by cardiogenic shock on admission.
    Rodrigues A; Araújo D; Silva PF; Braga P; Gonçalves M; Simões L; Gama V
    Rev Port Cardiol; 2000 Mar; 19(3):291-7. PubMed ID: 10804775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dynamics of experimental myocardial infarct complicated by cardiogenic shock during treatment with neuroleptanalgesia].
    Gordadze NG; Tsagareli ZG
    Arkh Patol; 1985; 47(4):27-35. PubMed ID: 4004585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemodynamics, therapy and mortality following myocardial infarct].
    Wollheim E
    Munch Med Wochenschr; 1970 Apr; 112(14):605-16. PubMed ID: 5467566
    [No Abstract]   [Full Text] [Related]  

  • 31. [Problems in the treatment of cardiogenic shock in myocardial infarct].
    Mihail A; Popescu P
    Med Interna (Bucur); 1969 Nov; 21(11):1301-10. PubMed ID: 5379697
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of cardiogenic shock complicating myocardial infarct by the methods of counterpulsation].
    Barvyn' VG; Bil'kovskiĭ PI; Aronov AE; Gorlova EB; Ivanov KM
    Kardiologiia; 1975 Apr; 15(4):72-9. PubMed ID: 1142634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the risk of intravenous administration of morphine in cardiogenic shock in patients with myocardial infarct].
    Liashenko MM; Kokhmaniuk IuS
    Sov Med; 1966 Jan; 29(1):90-4. PubMed ID: 5985171
    [No Abstract]   [Full Text] [Related]  

  • 34. [Transportation of patients with myocardial infarct complicated by cardiogenic shock and the use of countershock via an intra-aortic balloon].
    Barvyn' VG; Kaverin NM; Gorodkov VG; Perimov IuA
    Kardiologiia; 1978 Jan; 18(1):56-62. PubMed ID: 628146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States.
    Fang J; Mensah GA; Alderman MH; Croft JB
    Am Heart J; 2006 Dec; 152(6):1035-41. PubMed ID: 17161048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial.
    Singh M; White J; Hasdai D; Hodgson PK; Berger PB; Topol EJ; Califf RM; Holmes DR
    J Am Coll Cardiol; 2007 Oct; 50(18):1752-8. PubMed ID: 17964038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acid-base state in patients with myocardial infarct complicated by shock].
    Teplova NN
    Kardiologiia; 1969 Mar; 9(3):26-34. PubMed ID: 5361935
    [No Abstract]   [Full Text] [Related]  

  • 38. [Assessment of clinical course of myocardial infarction complicated by atrioventricular conduction disorders].
    Bacior B
    Przegl Lek; 1992; 49(11):359-61. PubMed ID: 1306566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of left heart bypass in experimental cardiogenic shock.
    MacFarlane JK; Scott HJ; Cronin RF
    J Thorac Cardiovasc Surg; 1969 Feb; 57(2):214-24. PubMed ID: 5764129
    [No Abstract]   [Full Text] [Related]  

  • 40. [Shock: changes in perspectives. Differential therapeutic problems in intensive care of shock].
    Schuster HP
    Internist (Berl); 1982 Aug; 23(8):463-9. PubMed ID: 6752087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.